Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX

Delayed Quote. Delayed  - 06/24 10:00:02 pm
81.9 USD   -7.14%
06/18 VERTEX PHARMACE : (VRTX) Stock Rating Reaffirmed by Jefferies Group
06/17 VERTEX PHARMACE : Orkambi’s cost too high for benefit offered,..
06/10 VERTEX PHARMACE : Announces Presentations of Data for KALYDECO® (iva..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/20/2016 06/21/2016 06/22/2016 06/23/2016 06/24/2016 Date
86.72(c) 85.28(c) 85.22(c) 88.2(c) 81.9(c) Last
1 273 069 1 881 940 1 917 796 1 397 980 2 169 446 Volume
-0.01% -1.66% -0.07% +3.50% -7.14% Change
More quotes
Financials ($)
Sales 2016 1 784 M
EBIT 2016 280 M
Net income 2016 37,8 M
Finance 2016 414 M
Yield 2016 -
Sales 2017 2 577 M
EBIT 2017 898 M
Net income 2017 634 M
Finance 2017 1 437 M
Yield 2017 -
P/E ratio 2016 729,30
P/E ratio 2017 34,21
EV / Sales2016 11,1x
EV / Sales2017 7,30x
Capitalization 20 258 M
More Financials
Company
Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets.It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious... 
More about the company
Surperformance© ratings of Vertex Pharmaceuticals Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on VERTEX PHARMACEUTICALS INC
06/23 VERTEX PHARMACEUTICALS : Reports from Vertex Pharmaceuticals Describe Recent Adv..
06/18 VERTEX PHARMACEUTICALS INCORPORATED : (VRTX) Stock Rating Reaffirmed by Jefferie..
06/17 VERTEX PHARMACEUTICALS : Orkambi’s cost too high for benefit offered, says..
06/16 VERTEX PHARMACEUTICALS : New Findings from Vertex Pharmaceuticals Inc. in the Ar..
06/15 VERTEX PHARMACEUTICALS INC / MA : Change in Directors or Principal Officers (for..
06/10 VERTEX PHARMACEUTICALS : Announces Presentations of Data for KALYDECO® (ivacafto..
06/09 VERTEX PHARMACEUTICALS : U.S. FDA Accepts for Priority Review Supplemental New D..
06/09 VERTEX PHARMACEUTICALS : to Present at the Goldman Sachs Healthcare Conference o..
06/02 VERTEX PHARMACEUTICALS : Spero Therapeutics Acquires Novel Gyrase Inhibitors fro..
06/02 VERTEX PHARMACEUTICALS : Study Results from Vertex Pharmaceuticals Provide New I..
More news
Sector news : Bio Therapeutic Drugs
06/24DJMedpace Files for IPO
06/24DJMEDIVATION : Glass Lewis Backs Medivation Board in Sanofi Dispute
06/24 MEDIVATION : Glass Lewis Recommends Medivation's Stockholders Support the Compan..
06/24 MEDIVATION : Glass Lewis Recommends Medivation’s Stockholders Support the ..
06/24 QUINTILES : Introduces Continuous Glucose Monitoring Services to Improve Diabete..
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
06/20 BIOTECH FORUM DAILY DIGEST : Bioitech Ready To Bounce Back On Brexit Polls. FDA'..
06/20 REGENERON GENERATES NEGATIVE ALPHA : Buy, Sell Or Hold?
06/20 Scattered Sectors In 2016; Best And Worst Performing S&P 500 Stocks YTD
06/13 Gilead Sciences Is On The Cusp Of A Breakthrough In NASH.
05/31 FDA accepts Vertex Pharma's application for expanded use of Orkambi; action d..
Advertisement
Chart VERTEX PHARMACEUTICALS INC
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Full-screen chart
Technical analysis trends VERTEX PHARMACEUT...
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions